Sort
16,300 grants matching “fatty liver disease”
Mechanisms of Eosinophilic Inflammation in Human Disease
$396,886Hirohito Kita · Mayo Clinic Rochester · R56 · FY2012 · AI
NASH Clinical Research Network
$396,804Anna Mae Elizabeth Diehl · Duke University · U01 · FY2017 · DK
Role of SH2-B in Glucose Metabolism
$396,795Liangyou Rui · University Of Michigan At Ann Arbor · R01 · FY2010 · DK
Metabolism of the VLDL receptor and ApoE receptor 2
$396,771Joachim J Herz · Ut Southwestern Medical Center · R37 · FY2012 · HL
Apolipoprotein conformation in amyloid and cardiovascular diseases
$396,753Olga Gursky · Boston University Medical Campus · R01 · FY2017 · GM
Nuclear Receptor Networks in Mucosal Immune Regulation
$396,660Mark Scott Sundrud · Dartmouth-Hitchcock Clinic · U01 · FY2025 · AI
Regulation of Cholesterol Catabolism by Bile Acids
$396,500Jongsook Kim Kemper · University Of Illinois At Urbana-Champaign · R01 · FY2019 · DK
Regulation of Cholesterol Catabolism by Bile Acids
$396,500Jongsook Kim Kemper · University Of Illinois At Urbana-Champaign · R01 · FY2020 · DK
Regulation of Cholesterol Catabolism by Bile Acids
$396,500Jongsook Kim Kemper · University Of Illinois At Urbana-Champaign · R01 · FY2021 · DK
Hepatic Nicotinamide N-Methyltransferase (NNMT) as a Pathogenetic Mechanism and Therapeutic Target for Alcoholic Liver Disease
$396,461Zhenyuan Song · University Of Illinois At Chicago · R01 · FY2023 · AA
Avoiding toxicity associated with MTP ablation
$396,458M Mahmood Hussain · Suny Downstate Medical Center · R01 · FY2010 · HL
Role of Adipose in Ethanol-Induced Tissue Injury
$396,436Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · R37 · FY2012 · AA
Control of stellate cells-driven liver cancer by the p62/NBR1 adapters
$396,371Jorge Moscat · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · DK
RNA m6A methylation contributes to hepatic inflammation in obesity-associated NAFLD
$396,349Xinshou Ouyang · Yale University · R01 · FY2023 · DK
Role of the Gut Microbiota and TLR4 in Alcoholic Hepatocarcinogenesis
$396,347Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2014 · AA
USC Cirrhosis Clinical Center
$396,266Norah A. Terrault · University Of Southern California · U01 · FY2025 · DK
Oxidant resistant apoA1 in reverse cholesterol transport, inflammation and atherosclerosis
$396,250Jonathan D Smith · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · HL
Metabolism of the VLDL receptor and ApoE receptor 2
$396,250Joachim J Herz · Ut Southwestern Medical Center · R37 · FY2011 · HL
The molecular basis of liver induced retinal blood vessel plasticity.
$396,250Jonathan E Sears · Cleveland Clinic Lerner Com-Cwru · R01 · FY2015 · EY
An anti-diabetic microRNA that promotes metabolically healthy obesity
$396,250Sean Hartig · Baylor College Of Medicine · R01 · FY2021 · DK
The molecular basis of liver induced retinal blood vessel plasticity.
$396,250Jonathan E Sears · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · EY
An anti-diabetic microRNA that promotes metabolically healthy obesity
$396,250Sean Hartig · Baylor College Of Medicine · R01 · FY2017 · DK
Oxidant resistant apoA1 in reverse cholesterol transport, inflammation and atherosclerosis
$396,250Jonathan D Smith · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · HL
Enzymatic Control of Trimethylamineoxide (TMAO)Induced Atherosclerosis
$396,250Jonathan Mark Brown · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · HL
An anti-diabetic microRNA that promotes metabolically healthy obesity
$396,250Sean Hartig · Baylor College Of Medicine · R01 · FY2019 · DK